Sanofi is an institution, managing $260.4M across 9 long positions as of Q3 2025 with 96% Healthcare concentration, with only 9 positions, and 39% allocation to MGTX.
Largest long holdings in Sanofi's portfolio (100% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $100.4M | 38.56% | — | 15.16% 12.2M shares | |
Biotechnology Healthcare | $59.7M | 22.91% | — | 4.24% 6.9M shares | |
Biotechnology Healthcare | $39.0M | 14.98% | — | 7.99% 1.2M shares | |
Biotechnology Healthcare | $25.2M | 9.67% | — | 2.94% 821.9K shares | |
Biotechnology Healthcare | $19.0M | 7.28% | +$19.0M New | 4.28% 2.7M shares | |
Unknown Unknown | $11.6M | 4.46% | — | 0.91% 524.9K shares | |
Biotechnology Healthcare | $3.0M | 1.15% | — | 7.30% 1.9M shares | |
Biotechnology Healthcare | $2.1M | 0.81% | — | 1.36% 815.0K shares | |
Biotechnology Healthcare | $483.3K | 0.19% | — | 2.00% 244.1K shares |
Portfolio activity, position movements, and quarter-over-quarter changes in Sanofi's latest filing
| Position | Shares Δ |
|---|---|
New |
| Position | Shares Δ |
|---|---|
Sold | |
Sold |
Portfolio insights and performance metrics for Sanofi
We use cookies for analytics. See our Privacy and Cookie Policy.